Breaking News

Hormonal birth control and breast cancer risk; NIH rejects bid to sidestep patents for cancer drug

March 24, 2023
A study puts into question the idea that a local application like an IUD has a different cancer risk from, for example, a minipill.
Adobe

Study finds same small rise in breast cancer risk in many forms of hormonal birth control

The absolute increased risk is small for all such birth control, but the study throws into question the idea that it is lower for IUDs.

By Angus Chen


STAT+ | NIH rejects bid to cut a cancer drug's price by sidestepping patents

"The decision gives pharmaceutical companies license to charge American citizens whatever price" they want, said cancer patient Robert Sachs

By Ed Silverman


Stanford scientist who broke genome sequencing record on what faster diagnoses mean for patients

Stanford cardiologist Euan Ashley and his team broke a world record last year for sequencing a full human genome in just over five hours.

By Jonathan Wosen



Alex Hogan/STAT

'It's a universal experience': Doctor who treats Boston's homeless population on why community is vital to health

Physician Jim O'Connell says his nonprofit is "not solving homelessness, but caring, as best we can, for those who are currently suffering."

By Ambar Castillo


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Cancer Briefing? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2023, All Rights Reserved.

No comments